Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): A clinical, ultrasound, and biomarker-based effectiveness after discontinuation and reinitiation of biosimilar infliximab.
Saved in:
| Title: | Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): A clinical, ultrasound, and biomarker-based effectiveness after discontinuation and reinitiation of biosimilar infliximab. |
|---|---|
| Authors: | Shimizu T; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Kawashiri SY; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Departments of Community Medicine, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Koga T; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Kiya R; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Morita M; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Kuroda S; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Tashiro S; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Morimoto S; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Yano H; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Ueki Y; Department of Rheumatology, Hakujyujikai Sasebo Chuo Hospital, Sasebo, Japan., Dobashi H; Division of Rheumatology, Department of Internal Medicine, Kagawa University Hospital, Kagawa, Japan., Nozaki Y; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan., Hosogaya N; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Yamamoto H; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Kawakami A; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. |
| Source: | Global health & medicine [Glob Health Med] 2025 Aug 31; Vol. 7 (4), pp. 334-339. |
| Publication Type: | Letter |
| Journal Info: | Publisher: National Center for Global Health and Medicine Country of Publication: Japan NLM ID: 101771579 Publication Model: Print Cited Medium: Internet ISSN: 2434-9194 (Electronic) Linking ISSN: 24349186 NLM ISO Abbreviation: Glob Health Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40895383 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): A clinical, ultrasound, and biomarker-based effectiveness after discontinuation and reinitiation of biosimilar infliximab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shimizu+T%22">Shimizu T</searchLink>; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Kawashiri+SY%22">Kawashiri SY</searchLink>; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Departments of Community Medicine, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Koga+T%22">Koga T</searchLink>; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Kiya+R%22">Kiya R</searchLink>; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Morita+M%22">Morita M</searchLink>; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Kuroda+S%22">Kuroda S</searchLink>; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Tashiro+S%22">Tashiro S</searchLink>; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Morimoto+S%22">Morimoto S</searchLink>; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Yano+H%22">Yano H</searchLink>; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Ueki+Y%22">Ueki Y</searchLink>; Department of Rheumatology, Hakujyujikai Sasebo Chuo Hospital, Sasebo, Japan.<br /><searchLink fieldCode="AU" term="%22Dobashi+H%22">Dobashi H</searchLink>; Division of Rheumatology, Department of Internal Medicine, Kagawa University Hospital, Kagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Nozaki+Y%22">Nozaki Y</searchLink>; Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hosogaya+N%22">Hosogaya N</searchLink>; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+H%22">Yamamoto H</searchLink>; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Kawakami+A%22">Kawakami A</searchLink>; Departments of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101771579%22">Global health & medicine</searchLink> [Glob Health Med] 2025 Aug 31; Vol. 7 (4), pp. 334-339. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22National+Center+for+Global+Health+and+Medicine%22">National Center for Global Health and Medicine </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>101771579 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2434-9194 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224349186%22">24349186 </searchLink><i>NLM ISO Abbreviation: </i>Glob Health Med <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40895383 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.35772/ghm.2025.01054 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 334 Titles: – TitleFull: Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II): A clinical, ultrasound, and biomarker-based effectiveness after discontinuation and reinitiation of biosimilar infliximab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shimizu T – PersonEntity: Name: NameFull: Kawashiri SY – PersonEntity: Name: NameFull: Koga T – PersonEntity: Name: NameFull: Kiya R – PersonEntity: Name: NameFull: Morita M – PersonEntity: Name: NameFull: Kuroda S – PersonEntity: Name: NameFull: Tashiro S – PersonEntity: Name: NameFull: Morimoto S – PersonEntity: Name: NameFull: Yano H – PersonEntity: Name: NameFull: Ueki Y – PersonEntity: Name: NameFull: Dobashi H – PersonEntity: Name: NameFull: Nozaki Y – PersonEntity: Name: NameFull: Hosogaya N – PersonEntity: Name: NameFull: Yamamoto H – PersonEntity: Name: NameFull: Kawakami A IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 08 Text: 2025 Aug 31 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2434-9194 Numbering: – Type: volume Value: 7 – Type: issue Value: 4 Titles: – TitleFull: Global health & medicine Type: main |
| ResultId | 1 |
